Literature DB >> 29450467

The Danger of Applying the ProtecT Trial to Minority Populations.

Shearwood McClelland1, Timur Mitin1.   

Abstract

Mesh：

Year:  2018        PMID： 29450467     DOI： 10.1001/jamaoncol.2017.5452

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Radiation oncology crossword: Genitourinary cancer.

Authors:  Shearwood McClelland; Timur Mitin; Charles R Thomas
Journal:  Rep Pract Oncol Radiother       Date:  2019-04-05

2.  Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.

Authors:  Shearwood McClelland; Oluwadamilola Sosanya; Timur Mitin; Catherine Degnin; Yiyi Chen; Albert Attia; John H Suh; Jerry J Jaboin
Journal:  J Neurooncol       Date:  2018-07-09       Impact factor: 4.130

3.  Adjuvant vs. salvage radiation therapy in men with high-risk features after radical prostatectomy: Survey of North American genitourinary expert radiation oncologists.

Authors:  Shearwood McClelland; Kiri A Sandler; Catherine Degnin; Yiyi Chen; Timur Mitin
Journal:  Can Urol Assoc J       Date:  2018-10-15       Impact factor: 1.862

4.  Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.

Authors:  Rishi Deka; P Travis Courtney; J Kellogg Parsons; Tyler J Nelson; Vinit Nalawade; Elaine Luterstein; Daniel R Cherry; Daniel R Simpson; Arno J Mundt; James D Murphy; Anthony V D'Amico; Christopher J Kane; Maria Elena Martinez; Brent S Rose
Journal:  JAMA       Date:  2020-11-03       Impact factor: 56.272

5.  Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer.

Authors:  Hann-Hsiang Chao; Payal D Soni; Bassam Dahman; Spiro C Stilianoudakis; Hampton Ford; Raj Singh; Stephen J Freedland; Drew Moghanaki; Neha Vapiwala; Michael G Chang
Journal:  Cancer Med       Date:  2022-03-15       Impact factor: 4.711

6.  The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.

Authors:  Richard J Bryant; Jon Oxley; Grace J Young; Janet A Lane; Chris Metcalfe; Michael Davis; Emma L Turner; Richard M Martin; John R Goepel; Murali Varma; David F Griffiths; Ken Grigor; Nick Mayer; Anne Y Warren; Selina Bhattarai; John Dormer; Malcolm Mason; John Staffurth; Eleanor Walsh; Derek J Rosario; James W F Catto; David E Neal; Jenny L Donovan; Freddie C Hamdy
Journal:  BJU Int       Date:  2020-02-12       Impact factor: 5.588
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.